My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
COMPLIANCE INFO_2023
EnvironmentalHealth
>
EHD Program Facility Records by Street Name
>
A
>
ACACIA
>
420
>
2200 - Hazardous Waste Program
>
PR0539946
>
COMPLIANCE INFO_2023
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
6/21/2023 5:13:45 PM
Creation date
2/1/2023 11:32:47 AM
Metadata
Fields
Template:
EHD - Public
ProgramCode
2200 - Hazardous Waste Program
File Section
COMPLIANCE INFO
FileName_PostFix
2023
RECORD_ID
PR0539946
PE
2220
FACILITY_ID
FA0022841
FACILITY_NAME
LINACIA PHARMACY
STREET_NUMBER
420
Direction
W
STREET_NAME
ACACIA
STREET_TYPE
ST
City
STOCKTON
Zip
95203
CURRENT_STATUS
01
SITE_LOCATION
420 W ACACIA ST
P_LOCATION
01
P_DISTRICT
001
QC Status
Approved
Scanner
SJGOV\gmartinez
Tags
EHD - Public
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
31
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Management of RCRA/Hazardous Pharmaceutical Waste Page 2 of-7 <br /> Conservation and Recovery Act(RCRA),including chemotherapy/biotherapy wastes are stored, <br /> handled,packaged,transported and disposed of in accordance with all federal,state and local <br /> government regulations. <br /> III. Definitions: <br /> Hazardous Drugs (HD) -Drugs that are capable of causing toxicity to personnel and others who come <br /> in contact with them.Hazardous drugs pose a potential health risk to personnel who prepare,handle, <br /> administer and dispose of these drugs.Drugs may be classified as hazardous when they possess any <br /> one of the following characteristics: <br /> - Genotoxicity <br /> - Carcinogenicity <br /> -Teratogenicity <br /> -Reproductive toxicity <br /> -Organ toxicity at low doses <br /> -Structure and toxicity profiles of new drugs mimic existing drugs determined to be hazardous by the <br /> above criteria <br /> -Potential exposure routes to hazardous drugs may occur through inhalation, skin contact, skin <br /> absorption, ingestion or injection. <br /> P-listed waste-includes unused, commercial chemical products that are acutely hazardous waste when <br /> discarded.The P-list can be found in Federal regulations. <br /> U-listed waste-includes unused, commercial chemical products that are hazardous waste when <br /> discarded. The U-list can be found in Federal regulations. <br /> Ignitability characteristic-identifies hazardous wastes that can create fires under certain conditions, <br /> are spontaneously combustible, or have a flash point of less than 60°C(140 °F). <br /> Corrosivity characteristic-identifies wastes that are acids or bases (aqueous solutions with pH less <br /> than or equal to 2, or greater than or equal to 12.5) or liquids that are capable of corroding metal <br /> containers. <br /> Reactivity characteristic-identifies wastes that readily explode or undergo violent reactions or <br /> release toxic gases or fumes when heated,compressed, or mixed with water <br /> Toxicity characteristic-identifies wastes likely to leach dangerous concentrations of toxic chemicals <br /> into ground water. <br /> D-listed wastes—identifies wastes possessing one or more characteristics of Ib itability, Corrosivity, <br /> Reactivity, or Toxicity <br /> N. Text: <br /> Regulatory bodies that oversee pharmaceutical waste management are: <br /> A. Environmental ProtectionAgency(EPA) <br /> B. Department of Transportation (DOT) <br /> C. Drug Enforcement Agency.(DEA) <br /> D. Occupational Safety and Health Administration(OSHA) <br /> E. California Department of Public Health(CDPH) <br /> F. California State.Pharmacy Board <br /> G. Local Publicly Owned Treatment Works (POTW) <br /> htto:Hdhalts01/Dolicy/policy.nsf/2bO 145f9f8l 8Obc28725727600642564/l a68480abe9cecfl... 3/18/2015 <br />
The URL can be used to link to this page
Your browser does not support the video tag.